tradingkey.logo
tradingkey.logo
Buscar

Quest Diagnostics Inc

DGX
Añadir a la lista de seguimiento
188.329USD
-1.851-0.97%
Horarios del mercado ETCotizaciones retrasadas 15 min
20.90BCap. mercado
20.45P/E TTM

Quest Diagnostics Inc

188.329
-1.851-0.97%

Más Datos de Quest Diagnostics Inc Compañía

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

Información de Quest Diagnostics Inc

Símbolo de cotizaciónDGX
Nombre de la empresaQuest Diagnostics Inc
Fecha de salida a bolsaDec 17, 1996
Director ejecutivoDavis (James E)
Número de empleados45000
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 17
Dirección500 Plaza Drive
CiudadSECAUCUS
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07094
Teléfono19735202700
Sitio Webhttps://www.questdiagnostics.com/
Símbolo de cotizaciónDGX
Fecha de salida a bolsaDec 17, 1996
Director ejecutivoDavis (James E)

Ejecutivos de Quest Diagnostics Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
71.62K
-1.68%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
46.45K
+1.80%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
43.30K
+9.07%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
29.57K
-12.98%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
26.30K
--
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
17.17K
+0.40%
Mr. Karthik Kuppusamy
Mr. Karthik Kuppusamy
Senior Vice President - Clinical Solutions
Senior Vice President - Clinical Solutions
15.50K
+0.25%
Ms. Denise M. Morrison
Ms. Denise M. Morrison
Independent Director
Independent Director
11.92K
+0.56%
Ms. Tracey C. Doi
Ms. Tracey C. Doi
Independent Director
Independent Director
6.58K
+1.72%
Mr. Robert B. (Rob) Carter
Mr. Robert B. (Rob) Carter
Independent Director
Independent Director
2.71K
+0.26%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
71.62K
-1.68%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
46.45K
+1.80%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
43.30K
+9.07%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
29.57K
-12.98%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
26.30K
--
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
17.17K
+0.40%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Routine clinical testing services
5.96B
54.00%
Gene-based and esoteric testing services
4.19B
38.00%
Anatomic pathology testing services
662.10M
6.00%
All other
220.70M
2.00%
COVID-19 testing services
0.00
0.00%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
11.04B
100.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Routine clinical testing services
5.96B
54.00%
Gene-based and esoteric testing services
4.19B
38.00%
Anatomic pathology testing services
662.10M
6.00%
All other
220.70M
2.00%
COVID-19 testing services
0.00
0.00%

Estadísticas de accionistas

Actualizado: dom., 10 de may
Actualizado: dom., 10 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Vanguard Capital Management, LLC
6.46%
BlackRock Institutional Trust Company, N.A.
5.58%
T. Rowe Price Associates, Inc.
5.54%
Vanguard Portfolio Management, LLC
5.49%
State Street Investment Management (US)
4.86%
Otro
72.07%
Accionistas
Accionistas
Proporción
Vanguard Capital Management, LLC
6.46%
BlackRock Institutional Trust Company, N.A.
5.58%
T. Rowe Price Associates, Inc.
5.54%
Vanguard Portfolio Management, LLC
5.49%
State Street Investment Management (US)
4.86%
Otro
72.07%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
56.33%
Investment Advisor/Hedge Fund
29.63%
Research Firm
5.13%
Pension Fund
2.82%
Hedge Fund
2.76%
Bank and Trust
1.77%
Sovereign Wealth Fund
1.24%
Individual Investor
0.48%
Family Office
0.06%

Participación institucional

Actualizado: dom., 5 de abr
Actualizado: dom., 5 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
1896
110.61M
99.92%
-3.16M
2025Q4
1760
110.09M
99.89%
--
2025Q3
1807
110.10M
100.22%
-700.93K
2025Q2
1819
110.85M
98.75%
+3.78M
2025Q1
1805
107.66M
97.04%
-1.03M
2024Q4
1782
103.84M
96.80%
+1.47M
2024Q3
1731
102.61M
95.91%
+134.75K
2024Q2
1739
102.41M
97.25%
-2.03M
2024Q1
1743
104.12M
95.50%
-1.89M
2023Q4
1768
101.63M
97.47%
-890.08K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
6.17M
5.62%
+44.49K
+0.73%
Dec 31, 2025
T. Rowe Price Associates, Inc.
6.13M
5.58%
-707.60K
-10.35%
Dec 31, 2025
State Street Investment Management (US)
5.38M
4.9%
+158.62K
+3.04%
Dec 31, 2025
Boston Partners
3.91M
3.56%
-123.56K
-3.06%
Dec 31, 2025
JP Morgan Asset Management
3.74M
3.4%
-38.83K
-1.03%
Dec 31, 2025
Geode Capital Management, L.L.C.
3.03M
2.76%
-8.28K
-0.27%
Dec 31, 2025
Victory Capital Management Inc.
2.13M
1.94%
-217.55K
-9.28%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
1.93M
1.76%
+24.04K
+1.26%
Dec 31, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares U.S. Healthcare Providers ETF
3.1%
Madison Dividend Value ETF
2.17%
State Street SPDR S&P Health Care Services ETF
1.99%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
1.81%
First Trust Total US Market AlphaDEX ETF
1.8%
Invesco S&P 500 Equal Weight Health Care ETF
1.59%
Acruence Active Hedge US Equity ETF
1.26%
First Trust Health Care Alphadex Fund
1.21%
Timothy Plan High Dividend Stock ETF
1.19%
VictoryShares US Value Momentum ETF
1.01%
Ver más
iShares U.S. Healthcare Providers ETF
Proporción3.1%
Madison Dividend Value ETF
Proporción2.17%
State Street SPDR S&P Health Care Services ETF
Proporción1.99%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
Proporción1.81%
First Trust Total US Market AlphaDEX ETF
Proporción1.8%
Invesco S&P 500 Equal Weight Health Care ETF
Proporción1.59%
Acruence Active Hedge US Equity ETF
Proporción1.26%
First Trust Health Care Alphadex Fund
Proporción1.21%
Timothy Plan High Dividend Stock ETF
Proporción1.19%
VictoryShares US Value Momentum ETF
Proporción1.01%

Dividendos

Un total de 1.26B USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Feb 10, 2026
DGX.NB Interim Cash Dividend of gross USD 0.86 paid on Apr 20, 2026 going ex on Apr 06, 2026
Apr 06, 2026
Apr 20, 2026
Apr 06, 2026
Nov 11, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Jan 28, 2026 going ex on Jan 13, 2026
Jan 13, 2026
Jan 28, 2026
Jan 13, 2026
Aug 13, 2025
DGX.NB Final Cash Dividend of gross USD 0.8 paid on Oct 20, 2025 going ex on Oct 03, 2025
Oct 03, 2025
Oct 20, 2025
Oct 03, 2025
May 14, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 21, 2025 going ex on Jul 07, 2025
Jul 07, 2025
Jul 21, 2025
Jul 07, 2025
Jan 30, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 21, 2025 going ex on Apr 07, 2025
Apr 07, 2025
Apr 21, 2025
Apr 07, 2025
Nov 12, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jan 29, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Jan 29, 2025
Jan 14, 2025
Aug 14, 2024
DGX.NB Final Cash Dividend of gross USD 0.75 paid on Oct 21, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Oct 21, 2024
Oct 04, 2024
May 15, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 22, 2024 going ex on Jul 08, 2024
Jul 08, 2024
Jul 22, 2024
Jul 08, 2024
Feb 01, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 22, 2024 going ex on Apr 05, 2024
Apr 08, 2024
Apr 22, 2024
Apr 05, 2024
Nov 14, 2023
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 31, 2024 going ex on Jan 16, 2024
Jan 17, 2024
Jan 31, 2024
Jan 16, 2024
Ver más

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI